retatrutide clinical trial news Weight Loss Results:Trial Data and FDA Status Next-Level Obesity and Cardiovascular Care
Description
A small number of participants experienced gallbladder-related events or temporary elevations in bilirubin, but most cases were manageable and did not require permanent discontinuation of treatment
11 untreated) patients, in whom a 72-hour i.v
However, they are not a one-size-fits-all solution
Professional societies: Recommend discontinuation at least 2 months prior to conception
Vico, D
These typically occur during the first few weeks and often improve with time
